Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

Metastatic relapse after treatment is the leading cause of cancer mortality, and known resistance mechanisms are missing for most treatments administered to patients. To bridge this gap, we analyze a pan-cancer cohort (META-PRISM) of 1,031 refractory metastatic tumors profiled via whole-exome and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradat, Yoann, Viot, Julien, Yurchenko, Andrey A., Gunbin, Konstantin, Cerbone, Luigi, Deloger, Marc, Grisay, Guillaume, Verlingue, Loic, Scott, Véronique, Padioleau, Ismael, Panunzi, Leonardo, Michiels, Stefan, Hollebecque, Antoine, Jules-Clément, Gérôme, Mezquita, Laura, Lainé, Antoine, Loriot, Yohann, Besse, Benjamin, Friboulet, Luc, André, Fabrice, Cournède, Paul-Henry, Gautheret, Daniel, Nikolaev, Sergey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157368/
https://www.ncbi.nlm.nih.gov/pubmed/36862804
http://dx.doi.org/10.1158/2159-8290.CD-22-0966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157368/
https://www.ncbi.nlm.nih.gov/pubmed/36862804
http://dx.doi.org/10.1158/2159-8290.CD-22-0966

Ejemplares similares